Eye drug safety check for premature babies in japan

This study is collecting information on how safe and effective Eylea eye injections are for Japanese babies with retinopathy of prematurity (ROP), an eye condition that affects premature infants. Researchers will follow 75 babies who are already receiving Eylea treatment as part of their regular care, observing them for 6 months to track any side effects and see if the treatment helps control their ROP. This is an observational study, meaning doctors are only collecting data during routine visits without changing the babies' treatment plans.